Long non-coding RNAs are emerging as crucial regulators and prognostic markers in
multiple cancers including non small cell lung cancer (NSCLC). In this study, we screened …

Recent studies have shown that long non-coding RNAs (lncRNAs) are involved in a variety
of biological processes and diseases in humans, including cancer. Our study serves as the …

Protein-coding genes represent only a small fraction of the human genome. In the past, the
majority of the genomic sequence has been considered transcriptionally silent, but recent …

Accumulating evidence supports an important role for the hepatitis B virus x protein (HBx) in
the pathogenesis of hepatitis B virus (HBV)-induced hepatocellular carcinoma (HCC), but …

Abstract p53 is the major mediator of the tumor suppressor response. It participates in
apoptosis and senescence and can respond to DNA damage. As a crucial sequence …

Recently, long noncoding RNAs (lncRNAs) are attracting wide attention in the field of cancer
research because of its important role in cancer diagnosis and prognosis. But studies on the …

There is still no suitable drug for pancreatic cancer treatment, which is one of the most
aggressive human tumors. Maternally expressed gene 3 (MEG3), a LncRNA, has been …

The long non-coding RNA maternally expressed gene 3 (MEG3) is frequently dysregulated
in human cancers; however, its roles in colorectal cancer (CRC) development are largely …

Recent studies have shown that long non-coding RNAs (lncRNAs) are involved in a number
of biological processes; however, further study is still warranted to comprehensively reveal …

Acute leukemias are genetic diseases caused by translocations or mutations, which
dysregulate hematopoiesis towards malignant transformation. However, the molecular mode …